FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2019

Fair Value Disclosures Abstract

Schedule of recurring fair value measurements

	Fair Value Measurements At Reporting Date
			Quoted prices		Significant		Significant		Measured at
	Balance at		in active		other observable		unobservable		Net Asset Value
	March 31,		markets		inputs		inputs		as a Practical
Description	2019		Level 1		Level 2		Level 3		Expedient (2)
	(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)	$	30,626	$	23,506	$	-	$	-	$	7,120
			Quoted prices		Significant		Significant		Measured at
	Balance at		in active		other observable		unobservable		Net Asset Value
	December 31,		markets		inputs		inputs		as a Practical
Description	2018		Level 1		Level 2		Level 3		Expedient (2)
	(amounts in thousands)
Liabilities
Deferred compensation plan liabilities (1)	$	30,928	$	23,476	$	-	$	-	$	7,452

Schedule Of Carrying Value Of Financial Instruments

	March 31,				December 31,
	2019				2018
	Carrying		Fair		Carrying		Fair
	Value		Value		Value		Value
	(amounts in thousands)
Term B Loans (1)	$	1,291,700	$	1,259,408	$	1,291,700	$	1,243,261
Revolver (2)	$	-	$	-	$	180,000	$	180,000
Senior Notes (3)	$	400,000	$	399,500	$	400,000	$	378,000
Other debt (4)	$	889			$	912
Letters of credit (4)	$	5,862			$	5,862

Schedule of Cost Method Investments Table Text Block

	Investments Valued Under the
	Measurement Alternative
	March 31,		December 31,
	2019		2018
		(amounts in thousands)
Investment balance before cumulative
impairment as of January 1,	$	11,205	$	9,955
Accumulated impairment as of January 1,		-		-
Investment beginning balance after cumulative
impairment as of January 1,		11,205		9,955
Acquisition of interest in a privately held company		-		1,250
Ending period balance	$	11,205	$	11,205